Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Luteal Phase Paroxetine for PMDD
NCT00620581Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of paroxetine in Premenstrual Dysphoric Disorder (PMDD), sponsored by Hamilton Health Sciences. Status: completed.
02
Drugs
paroxetine
03
Conditions
Premenstrual Dysphoric Disorder (PMDD)
Beyond the preview
Go deeper on NCT00620581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00620581.